Deloitte will look into a range of issues that also underpinned the 2019 review led by Professor Lloyd Sansom AO, including the "effectiveness, efficiency and appropriateness of the work delivered by NPS MedicineWise" and its governance and administrative arrangements. …
New review of NPS Medicinewise a virtual 're-run' of previous process
July 13, 2022 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Island Pharmaceuticals reports breakthrough survival data for galidesivir in Marburg and Ebola studies
September 17, 2025 - - Australian Biotech -
Australian Dementia Network Registry wants access to 'turning point' therapies
September 17, 2025 - - Latest News -
Pharmac proposes funding new ADHD medicine to tackle supply shortages
September 17, 2025 - - Latest News -
New data reveals deep inequities as Sanofi rolls out trust-building initiative
September 17, 2025 - - Latest News -
Ipsen appoints Dagmar Tschoep as general manager for Australia and New Zealand
September 16, 2025 - - Latest News -
Merck welcomes new director of market access, government affairs and communications
September 16, 2025 - - Latest News -
New mental health service takes aim at the silent struggle of undiagnosed ADHD
September 16, 2025 - - Latest News